AudioCure strives to protect its successful drug research by international patents. We are therefore very pleased, that the priority year of the Composition of Matter Patent „Fluorcarboline“ ended on September 29th. At the same time a supplemented version in the form...
AudioCure, in collaboration with Dr. Wernicke (Technical University of Applied Sciences, Wildau), and Dr. Enzensperger (University of Jena) has successfully tested the newly synthesized chemical entity AC102, a betacarboline, in an in vitro screening model. AC102 has...
The Technical University of Applied Sciences, Wildau biennially rewards outstanding achievements in both education and scientific research. In September, the Research Award 2013 went to the project: “Drug development for therapeutic and prophylactic treatments of...
AudioCure, met with federal minister and party head Dr. Philipp Rösler, on the occasion of a biotechnology function in Berlin. We were very pleased to be invited by the German Bundestag who aimed to bring an international group of investors together with highly...
High-Tech Gründerfonds and Business Angel Invest in AudioCure Pharma GmbH Drug Development AudioCure Pharma concentrates on the clinical development of drug candidates in neurological disease indications with a high unmet medical need. The lead candidate is a small...
This website uses cookies. By clicking on the “Ok” button, you consent to our use of cookies as described in our Privacy Notice. If you continue to use this site we will assume that you agree with our Privacy Police.OkRead more
